World Wires · story 5372 · unverified · 1 source(s)

Tectonic Therapeutic Announces Favorable Phase 1 Results for TX2100

Tectonic Therapeutic reported positive topline Phase 1a clinical trial results for TX2100, targeting hereditary hemorrhagic telangiectasia.

Open in the desk

Coverage

• Tectonic Therapeutic Announces Favorable Phase 1 Results for TX2100 GlobeNewswire: public companies · tier D · clear net · 2026-09-29 12:00 UTC

What this site indexes